Redmile Group, LLC Regenxbio Inc. Transaction History

Redmile Group, LLC

  • $1.53 Billion
  • Q3 2024

A detailed history of Redmile Group, LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 4,892,902 shares of RGNX stock, worth $46.9 Million. This represents 3.36% of its overall portfolio holdings.

Number of Shares
4,892,902
Previous 4,569,802 7.07%
Holding current value
$46.9 Million
Previous $53.5 Million 4.0%
% of portfolio
3.36%
Previous 3.49%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$10.49 - $14.39 $3.39 Million - $4.65 Million
323,100 Added 7.07%
4,892,902 $51.3 Million
Q2 2024

Aug 14, 2024
BUY
$11.51 - $21.53 $210,011 - $392,836
18,246 Added 0.4%
4,569,802 $53.5 Million
Q1 2024

May 15, 2024
BUY
$12.17 - $24.61 $9.62 Million - $19.5 Million
790,866 Added 21.03%
4,551,556 $95.9 Million
Q4 2023

Feb 14, 2024
BUY
$12.89 - $20.82 $22.4 Million - $36.1 Million
1,734,114 Added 85.57%
3,760,690 $67.5 Million
Q2 2023

Aug 14, 2023
BUY
$17.23 - $21.71 $6.65 Million - $8.38 Million
385,851 Added 23.52%
2,026,576 $40.5 Million
Q1 2023

May 15, 2023
SELL
$18.08 - $24.55 $4.93 Million - $6.7 Million
-272,787 Reduced 14.26%
1,640,725 $31 Million
Q4 2022

Feb 14, 2023
SELL
$20.4 - $24.73 $75,480 - $91,501
-3,700 Reduced 0.19%
1,913,512 $43.4 Million
Q3 2022

Nov 14, 2022
SELL
$22.29 - $35.04 $1.95 Million - $3.06 Million
-87,451 Reduced 4.36%
1,917,212 $50.7 Million
Q2 2022

Aug 15, 2022
BUY
$19.35 - $35.04 $536,769 - $972,009
27,740 Added 1.4%
2,004,663 $49.5 Million
Q1 2022

May 16, 2022
BUY
$24.62 - $34.31 $1.96 Million - $2.73 Million
79,700 Added 4.2%
1,976,923 $65.6 Million
Q4 2021

Feb 14, 2022
SELL
$30.19 - $40.28 $3.34 Million - $4.46 Million
-110,778 Reduced 5.52%
1,897,223 $62 Million
Q3 2021

Nov 15, 2021
SELL
$29.09 - $45.68 $3.79 Million - $5.95 Million
-130,200 Reduced 6.09%
2,008,001 $84.2 Million
Q2 2021

Aug 16, 2021
SELL
$32.46 - $40.48 $6.56 Million - $8.18 Million
-202,112 Reduced 8.64%
2,138,201 $83.1 Million
Q1 2021

May 17, 2021
BUY
$33.61 - $49.95 $7.29 Million - $10.8 Million
216,821 Added 10.21%
2,340,313 $79.8 Million
Q4 2020

Feb 16, 2021
SELL
$26.52 - $49.35 $2.78 Million - $5.17 Million
-104,674 Reduced 4.7%
2,123,492 $96.3 Million
Q3 2020

Nov 16, 2020
SELL
$27.01 - $40.26 $232,286 - $346,236
-8,600 Reduced 0.38%
2,228,166 $61.3 Million
Q2 2020

Aug 14, 2020
SELL
$27.75 - $43.44 $2.82 Million - $4.42 Million
-101,700 Reduced 4.35%
2,236,766 $82.4 Million
Q1 2020

May 15, 2020
SELL
$21.5 - $54.2 $3.65 Million - $9.21 Million
-169,920 Reduced 6.77%
2,338,466 $75.7 Million
Q4 2019

Feb 14, 2020
BUY
$34.54 - $44.87 $5.04 Million - $6.55 Million
145,900 Added 6.18%
2,508,386 $103 Million
Q3 2019

Nov 14, 2019
BUY
$31.84 - $50.88 $30.9 Million - $49.4 Million
971,110 Added 69.79%
2,362,486 $84.1 Million
Q2 2019

Aug 14, 2019
SELL
$42.0 - $59.29 $1.22 Million - $1.72 Million
-28,966 Reduced 2.04%
1,391,376 $71.5 Million
Q1 2019

May 15, 2019
BUY
$40.82 - $62.45 $2.68 Million - $4.1 Million
65,600 Added 4.84%
1,420,342 $81.4 Million
Q4 2018

Feb 14, 2019
SELL
$39.11 - $75.15 $11.8 Million - $22.6 Million
-301,323 Reduced 18.2%
1,354,742 $56.8 Million
Q3 2018

Nov 14, 2018
BUY
$65.0 - $82.15 $6.17 Million - $7.8 Million
94,890 Added 6.08%
1,656,065 $125 Million
Q2 2018

Aug 14, 2018
SELL
$27.2 - $74.35 $15.5 Million - $42.4 Million
-569,797 Reduced 26.74%
1,561,175 $112 Million
Q1 2018

May 15, 2018
BUY
$24.05 - $37.5 $17 Million - $26.5 Million
705,700 Added 49.51%
2,130,972 $0
Q4 2017

Feb 14, 2018
SELL
$26.0 - $34.6 $6.3 Million - $8.39 Million
-242,400 Reduced 14.54%
1,425,272 $47.4 Million
Q3 2017

Nov 14, 2017
BUY
$18.0 - $32.95 $30 Million - $54.9 Million
1,667,672
1,667,672 $55 Million

Others Institutions Holding RGNX

# of Institutions
197
Shares Held
43.2M
Call Options Held
104K
Put Options Held
478K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $414M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email